Breaking News

Eurofins Opens Central Lab in Bangalore

Offers full package of safety testing and biomarker testing

Eurofins Global Central Laboratory has opened a new Central Lab in Bangalore, India. Eurofins now has three central labs in the Asia-Pacific region, as well as lab facilities in the U.S., Europe, Singapore and China.

René van Erp, managing director Eurofins Global Central Laboratory, said, “Solely dedicated to providing laboratory testing in clinical trials, Eurofins Global Central Laboratory is uniquely positioned since only a few CROs offer a similar global footprint. This expansion of our global footprint allows us to bring more value to our customers, and makes Eurofins Global Central Laboratory a unique worldwide source for laboratory testing in clinical trials.”

The Bangalore facility offers a full package of safety testing, as well as biomarker testing, and is certified with the National Glycohemoglobin Standardization Program (NGSP) Level 1 accreditation. The company expects NABL and CAP accreditations within the first year of operation.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters